REBECCA RAMEY: Open Payments
NPI 1629381306 · PIKEVILLE, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$649 in 36 payments from 13 companies in 2025. Trend: 2023 $414 · 2024 $925 · 2025 $649
Food & beverage: $649
| Company | Payments | Amount |
|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, Inc. | 5 | $93 |
| Travere Therapeutics, Inc. | 7 | $92 |
| Grifols USA, LLC | 4 | $88 |
| Lilly USA, LLC | 4 | $74 |
| AstraZeneca Pharmaceuticals LP | 4 | $72 |
| Novo Nordisk Inc | 3 | $70 |
| GlaxoSmithKline, LLC. | 2 | $36 |
| PFIZER INC. | 2 | $35 |
| Mallinckrodt Hospital Products Inc. | 1 | $22 |
| AtriCure, Inc. | 1 | $22 |
Products named: JARDIANCE, Prolastin-C Liquid, Ozempic, AIRSUPRA, FARXIGA, TERLIVAZ, ATRICLIP LAA EXCLUSION SYSTEM, SHINGRIX.
Industry payments across KY — which companies pay providers there.
